Down syndrome with Alzheimer's disease brains have increased iron and associated lipid peroxidation consistent with

Max A Thorwald1, Jose A Godoy-Lugo1, Elizabeth Kerstiens1

  • 1Leonard Davis School of Gerontology, University of Southern California, 3715 McClintock Ave, Los Angeles, CA 90089.

Abstract

Insights

Down Syndrome with Alzheimer's Disease (DSAD) shows increased iron and lipid peroxidation compared to Alzheimer's Disease (AD). This suggests higher iron load in DSAD contributes to greater oxidative damage, impacting brain health.

Area of Science:

  • Neuroscience
  • Biochemistry
  • Genetics

Background:

  • Cerebral microbleeds (MB) are linked to Alzheimer's Disease (AD) and Down Syndrome with AD (DSAD).
  • Iron accumulation in MB may drive lipid peroxidation and neurodegeneration.
  • Amyloid precursor protein (APP) triplication in DSAD might exacerbate iron load and oxidative stress.

Purpose of the Study:

  • Investigate the relationship between amyloid deposition, iron load, and lipid peroxidation in AD and DSAD.
  • Examine proteins involved in iron metabolism, antioxidant response, and amyloid processing.

Main Methods:

  • Analyzed prefrontal cortex and cerebellum from cognitively normal (CTL), AD, and DSAD individuals (ApoE3,3 carriers).
  • Assessed proteins mediating iron metabolism, antioxidant defense, and amyloid processing within lipid rafts.

Main Results:

  • DSAD exhibited a 2-fold increase in iron compared to CTL and AD.
  • Increased iron storage proteins and lipid peroxidation were observed in the prefrontal cortex of DSAD and AD.
  • Glutathione synthesis protein GCLM decreased by 50% in both AD and DSAD.
  • Lipid raft-associated glutathione peroxidase 4 (GPx4) activity decreased by at least 30% in AD and DSAD.

Conclusions:

  • DSAD demonstrates more severe lipid peroxidation than AD, correlating with higher microbleed and iron burden.
  • These findings highlight the role of iron dysregulation and oxidative stress in the pathogenesis of DSAD.